Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bialystok
Clinical trial register · Poland

Clinical Trials in Bialystok, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 95 Lodz 80 Krakow 70 Poznan 67 Gdansk 59
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca52 Janssen Research & Development, LLC23 Merck Sharp & Dohme LLC23 Eli Lilly and Company20 Medical University of Bialystok19 Clear sponsor filter
Site location
Warsaw95 Lodz80 Krakow70 Poznan67 Gdansk59
All 81 locations
Target enrolment
to

Trials with a site in Bialystok

52 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Bialystok, Częstochowa, Gdynia, Katowice, Krakow, Poznan, Przemyśl, Radzionków
2026-08-24
Recruiting
AstraZeneca
Phase 3
7,000
Będzin, Bialystok, Czeladź, Gmina Świecie, Katowice, Kwidzyn, Lodz, Lublin
2026-08-21
Recruiting
AstraZeneca
Phase 3
1,500
Bialystok, Elblag, Gdynia, Katowice, Krakow, Legnica, Lodz, Poznan
2026-08-20
Recruiting
AstraZeneca
Phase 3
2,500
Bialystok, Elblag, Gdynia, Katowice, Krakow, Legnica, Lodz, Poznan
2026-08-19
Recruiting
AstraZeneca
Phase 3
600
Bialystok, Częstochowa, Kielce, Krakow, Lodz, Poznan, Radom, Warsaw
2026-07-08
Recruiting
AstraZeneca
Phase 3
2,000
Bialystok, Częstochowa, Kielce, Lodz, Lublin, Poznan, Radom, Warsaw
2026-07-06
Recruiting
AstraZeneca
Phase 3
1,200
Bialystok, Krakow, Lodz, Lublin, Poznan, Radom, Warsaw
2026-07-06
Recruiting
AstraZeneca
Phase 3
4,500
Bialystok, Bydgoszcz, Kielce, Krakow, Lodz, Lublin, Poznan, Radom
2026-06-29
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Bialystok, Krakow, Lodz, Poznan, Rzeszów, Warsaw
2026-06-11
Recruiting
AstraZeneca
Observational
2,150
Lublin, Krakow, Radom, Bialystok, Częstochowa, Poznan, Warsaw, Lodz
2026-05-06
Recruiting
AstraZeneca
Phase 2
100
Bialystok, Warsaw
2025-07-17
Recruiting
AstraZeneca
Phase 2
987
Bialystok, Bydgoszcz, Chęciny, Elblag, Karczew, Katowice, Komorniki, Ksawerów
2025-06-27
Recruiting
AstraZeneca
Phase 3
15,100
Bialystok, Bydgoszcz, Gdansk, Gdynia, Jelenia Góra, Katowice, Kędzierzyn-Koźle, Krakow
2025-06-04
Active, closed
AstraZeneca
Phase 3
3,103
Bialystok, Gdansk, Gdynia, Katowice, Kędzierzyn-Koźle, Krakow, Lodz, Lublin
2025-05-28
Recruiting
AstraZeneca
Phase 3
600
Bialystok, Gdansk, Lodz, Poznan, Siedlce, Szczecin
2025-03-27
Recruiting
AstraZeneca
Phase 3
990
Bialystok, Bydgoszcz, Chrzanów, Karczew, Katowice, Kielce, Krakow, Lodz
2025-03-18
Recruiting
AstraZeneca
Phase 3
11,300
Bialystok, Biała Podlaska, Bydgoszcz, Chojnice, Chrzanów, Częstochowa, Gdansk, Gdynia
2025-03-14
Recruiting
AstraZeneca
Phase 3
5,000
Bialystok, Gdynia, Gmina Świecie, Jasło, Katowice, Krakow, Lodz, Lublin
2025-03-03
Recruiting
AstraZeneca
Phase 3
840
Bialystok, Gdansk, Koszalin, Lodz, Olsztyn, Przemyśl, Tomaszów Mazowiecki, Warsaw
2025-03-01
Active, closed
Real-life Treatment Outcomes of Ravulizumab in PNH
NCT06633536Paroxysmal Nocturnal Haemoglobinuria
DrugRavulizumab
AstraZeneca
Observational
64
Bialystok, Brzozów, Bydgoszcz, Gdansk, Krakow, Lodz, Lublin, Opole
2025-02-06
Active, closed
AstraZeneca
Phase 3
181
Bialystok, Bydgoszcz, Lodz, Zawadzkie
2024-12-03
Recruiting
AstraZeneca
Phase 3
1,160
Bialystok, Biała Podlaska, Bydgoszcz, Bystra, Lodz, Lublin, Poznan, Warsaw
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,160
Bialystok, Biała Podlaska, Bydgoszcz, Bystra, Lodz, Lublin, Poznan, Warsaw
2024-11-18
Recruiting
AstraZeneca
Phase 3
620
Bialystok, Katowice, Krakow, Lublin, Warsaw, Wroclaw
2024-08-12
Recruiting
AstraZeneca
Phase 3
240
Bialystok, Krakow, Lodz, Poznan, Warsaw, Wroclaw
2024-06-20
Recruiting
AstraZeneca
Phase 3
5,250
Bialystok, Bydgoszcz, Chęciny, Chojnice, Częstochowa, Inowrocław, Karczew, Katowice
2024-02-21
Recruiting
AstraZeneca
Phase 3
1,145
Bialystok, Bielsko-Biala, Bydgoszcz, Gliwice, Olsztyn, Piotrkow Trybunalski, Siedlce, Tomaszów Mazowiecki
2023-12-14
Recruiting
AstraZeneca
Phase 3
625
Bialystok, Bydgoszcz, Gdansk, Gdynia, Konin, Krakow, Legnica, Lodz
2023-11-23
Active, closed
AstraZeneca
Phase 3
1,902
Bialystok, Bydgoszcz, Gdynia, Krakow, Lodz, Warsaw
2023-11-14
Active, closed
AstraZeneca
Phase 3
5,511
Bialystok, Biała Podlaska, Bydgoszcz, Gdansk, Gdynia, Koszalin, Krakow, Lodz
2023-10-05
Recruiting
AstraZeneca
Phase 3
800
Bialystok, Gdansk, Gliwice, Krakow, Lodz, Poznan, Warsaw, Wroclaw
2023-09-22
Active, closed
AstraZeneca
Phase 3
94
Bialystok, Krakow, Lodz, Skarżysko-Kamienna, Tarnów
2023-04-05
Recruiting
AstraZeneca
Phase 3
4,300
Bialystok, Grudziądz, Koszalin, Lodz, Lublin, Opole, Poznan, Racibórz
2023-03-31
Active, closed
AstraZeneca
Phase 3
644
Bialystok, Bydgoszcz, Lodz, Poznan, Warsaw, Wroclaw
2022-05-16
By invitation
AstraZeneca
Phase 3
214
Bialystok, Bydgoszcz, Elblag, Lodz, Olsztyn, Szczecin, Warsaw
2022-04-19
Active, closed
AstraZeneca
Phase 3
791
Bialystok, Gliwice, Katowice, Lodz, Warsaw, Wroclaw
2022-02-18
Active, closed
AstraZeneca
Phase 3
927
Bialystok, Biała Podlaska, Bydgoszcz, Koszalin, Lublin, Rzeszów, Warsaw
2021-10-25
Active, closed
AstraZeneca
Phase 3
732
Bialystok, Gdansk, Gdynia, Konin, Koszalin, Lodz, Tomaszów Mazowiecki, Warsaw
2021-10-18
Active, closed
AstraZeneca
Phase 3
957
Bialystok, Gdansk, Krakow, Lodz, Poznan, Warsaw
2020-11-17
Active, closed
AstraZeneca
Phase 3
370
Bialystok, Bydgoszcz, Poznan
2020-10-02
Active, closed
AstraZeneca
Phase 3
185
Bialystok, Grzepnica, Lublin, Olsztyn, Poznan
2020-08-04
Recruiting
AstraZeneca
Phase 3
140
Bialystok, Krakow, Lodz, Warsaw
2019-04-02
Active, closed
AstraZeneca
Phase 1
175
Bialystok, Bydgoszcz, Gdansk, Grudziądz, Lodz, Olsztyn, Tomaszów Mazowiecki, Warsaw
2018-12-27
Active, closed
AstraZeneca
Phase 2
401
Bialystok, Lodz, Poznan, Prabuty
2018-12-21
Active, closed
AstraZeneca
Phase 3
825
Bialystok, Olsztyn, Warsaw
2018-12-06
Active, closed
AstraZeneca
Phase 3
407
Bialystok, Gdansk, Poznan, Tomaszów Mazowiecki, Warsaw
2018-11-27
Active, closed
AstraZeneca
Phase 3
1,063
Bialystok, Gdansk, Grudziądz, Koszalin, Krakow, Olsztyn, Ostrołęka, Poznan
2018-11-16
Active, closed
AstraZeneca
Phase 3
1,246
Bialystok, Gdansk, Grudziądz, Koszalin, Krakow, Olsztyn, Poznan, Radom
2018-09-27
Active, closed
AstraZeneca
Phase 3
1,018
Bialystok, Gdansk, Grudziądz, Koszalin, Piotrkow Trybunalski, Poznan, Warsaw, Wroclaw
2018-05-14
Active, closed
AstraZeneca
Phase 3
987
Bialystok, Lublin, Olsztyn, Warsaw
2017-03-27
Active, closed
AstraZeneca
Phase 3
669
Bialystok, Grudziądz, Koszalin, Lublin, Mrozy, Warsaw, Wroclaw
2017-01-02
Active, closed
AstraZeneca
Phase 3
736
Bialystok, Lodz, Poznan
2005-02-13
Rows per page Showing 1–52 of 52
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-poland/city/bialystok

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 52 of those studies with a site in Bialystok that also match the filters currently applied.

How many clinical trials are recruiting in Bialystok?

28 of the 52 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 23 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bialystok), 52 studies
PhaseStudiesRecruitingShare
Phase 3452486.5%
Phase 2437.7%
Observational213.8%
Phase 1101.9%

Most active sponsors

Lead sponsors with the most studies (Bialystok)
Lead sponsorStudiesRecruiting
AstraZeneca5228
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.